Correlation Between Changes in Brand-Name Drug Prices and Patient Out-of-Pocket Costs

IMPORTANCE: List prices set by manufacturers for brand-name prescription drugs in the US have been increasing faster than inflation, although confidential manufacturer rebates offset some of these increases. Most commercially insured patients pay at least some out-of-pocket costs for prescription dr...

Descripción completa

Detalles Bibliográficos
Autores principales: Rome, Benjamin N., Feldman, William B., Desai, Rishi J., Kesselheim, Aaron S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8097497/
https://www.ncbi.nlm.nih.gov/pubmed/33944925
http://dx.doi.org/10.1001/jamanetworkopen.2021.8816

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8097497/
https://www.ncbi.nlm.nih.gov/pubmed/33944925
http://dx.doi.org/10.1001/jamanetworkopen.2021.8816

Ejemplares similares